AIDX

20/20 Biolabs, Inc. Common Stock

0.54

USD

-0.02

-4.29%

Sep 10, 15:46 UTC -4

Closed

Pre-Market

0.55

+0.01

+2.52%

20/20 Biolabs, Inc. Common Stock Profile

About

20/20 BioLabs Inc. is an early market in cutting-edge, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. 20/20 BioLabs Inc. is based in GAITHERSBURG, Md.

Info & Links

CEO

Jonathan Cohen

Headquarters

15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877, UNITED STATES

Auditor

dbbmckennon

Share holders

8,351

Employees

20/20 Biolabs, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

7.07M

Enterprise Value

2.53M

Enterprise Value/EBITDA(ttm)

-1.18

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

4.37

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

14.88%

Operating Margin(ttm)

Profit Margin(ttm)

-244.22%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-126.56%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

1.08M

Revenue Per Share(ttm)

0.08

Gross Profit(ttm)

367.60K

EBITDA(ttm)³

-2.14M

Net Income Available to Common(ttm)

-4.87M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

S&P 500 52-Week Change

17.72%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

12.77M

Dividend Yield

0.00%

Float⁴

8.96M

% Held by Insiders

29.80%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

4.55M

Total Cash Per Share(mrq)

0.36

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.99%

Quick Ratio(mrq)

1.95%

Book Value Per Share(mrq)

0.26

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.18

Free Cash Flow(ytd)

-1.89M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.